Regorafenib
Inquiry
Post Date: | Feb 14,2016 |
Expiry Date: | Feb 13,2017 |
Detailed Description: |
Cas No. :755037-03-7
Quantity: 500Kilograms Specs:99% Payment Method: T/T, L/C at sight English name: Regorafenib Synonyms:Regorafenib;BAY73-4506;4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide;BAY 73-4506(Regorafenib);4-[4-({[4-chioro-3-(trifluoroMethyl)phenyl]carbaMoyl}aMino)-3-fluorophenoxy]-pyridine-2-carboxylic acid MethylaMide; Regorafenib (BAY 73-4506);4-[4-[[[[4-Chloro-3-(trifluoroMethyl)phenyl]aMino]carbonyl]aMino]-3-fluorophenoxy]-N-Methyl-2-pyridinecarboxaMide;4-[4-[N'-(4-Chloro-3-trifluoroMethylphenyl)ureido]-3- fluorophenoxy]pyridine-2-carboxylic Acid MethylaMide CAS No.: 755037-03-7 Molecular formula: C21H15ClF4N4O3 Molecular weight: 482.8154128 Application: Is a new kind of multiple kinase inhibitor, can block a variety of enzyme that promotes cancer growth. Used in the treatment of metastatic colorectal cancer. Has a positive role in antitumor activity, can be used as second-line therapy for terminal-stage liver cancer patients. |
CAS Registry Number: | 755037-03-7 |
Synonyms: | ;BAY 73-4506;Regorafenib; |
Molecular Formula: | C21H15ClF4N4O3 |
Molecular Weight: | 482.82 |
Molecular Structure: |
Company: | Ji'nan Orgachem Pharmaceutical Co.,Ltd. [ China ] |
Contact: | Violet |
Tel: | 0531-82687809 |
Fax: | 0531-82687807 |
Email: | violet.8999@163.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.